1. The Role of Point-of-Care Anticoagulation Monitoring in Arterial and Venous Thromboembolic Disorders

   • Christopher R. Zimmerman

   OriginalPaper Pages: 187 - 198

2. Assessing the Optimal Level of Platelet Inhibition with GPIIb/IIIa Inhibitors in Patients Undergoing Coronary Intervention. Rationale and Design of the GOLD Study

   • Steven R. Steinhubl

   OriginalPaper Pages: 199 - 205

3. Early and Pre-Discharge Aspirin Administration Among Patients with Acute Myocardial Infarction: Current Clinical Practice and Trends in the United States

   • Richard C. Becker
   • Maureen Burns
   • William J. Rogers

   OriginalPaper Pages: 207 - 215

4. Circulating Levels of IL-1β, a Prothrombotic Cytokine, are Elevated in Unstable Angina Versus Stable Angina

   • Alan D. Simon
   • Shahram Yazdani
   • LeRoy E. Rabbani

   OriginalPaper Pages: 217 - 222

5. Enoxaparin, a Low Molecular Weight Heparin, Inhibits Platelet-Dependent Prothrombinase Assembly and Activity by Factor-Xa Neutralization

   • Frederick A. Spencer
   • Steven P. Ball
   • Richard C. Becker

   OriginalPaper Pages: 223 - 228

6. Moderate Alcohol Consumption is Associated with Decreased Platelet Activity in Patients Presenting with Acute Myocardial Infarction

   • Victor L. Serebruany
   • David R. Lowry
   • Paul A. Gurbel

   OriginalPaper Pages: 229 - 234

7. Bridging the Gap with New Strategies in Acute ST Elevation Myocardial Infarction: Bolus Thrombolysis, Glycoprotein IIb/IIIa Inhibitors, Combination Therapy, Percutaneous Coronary Intervention, and “Facilitated” PCI

   • Christopher P. Cannon

   OriginalPaper Pages: 235 - 241

8. Does Ultrasound Influence Experimentally Induced Thrombus Formation in the Central Artery of the Rabbit Ear?

   • Johan Nordquist
   • Jonas Carlson
   • Lars Salemark

   OriginalPaper Pages: 243 - 249

9. High Shear Stress Marks: The Vulnerable Target with von Willebrand Factor for Platelet Deployment

   • Harel Gilutz

   OriginalPaper Pages: 251 - 252

10. A Guide to Venous Thromboembolism Risk Factor Assessment

    • Gary D. Motykie
    • Lukas P. Zebala
    • Eric B. Cohen

    OriginalPaper Pages: 253 - 262

11. Monitoring Therapy with Vitamin K Antagonists in Patients with Lupus Anticoagulant: Effect on Different Tests for INR Determination

    • Nick R. Bijsterveld
    • Saskia Middeldorp
    • Harry R. Büller

    OriginalPaper Pages: 263 - 269

12. Symptomatic Combined Homozygous Factor XII Deficiency and Heterozygous Factor V Leiden

    • A. Girolami
    • P. Simioni
    • P. Zerbinati

    OriginalPaper Pages: 271 - 275

13. Decrease in Protein C Inhibitor Activity and Acquired APC Resistance During Normal Pregnancy

    • He Shu
    • Margareta Wramsby
    • Katarina Bremme

    OriginalPaper Pages: 277 - 281

14. Relationship Between Test Frequency and Outcomes of Anticoagulation: A Literature Review and Commentary with Implications for the Design of Randomized Trials of Patient Self-Management

    • Gregory P. Samsa
    • David B. Matchar

    OriginalPaper Pages: 283 - 292

15. Applications of Anti-Platelet Monitoring in Catheterization Laboratory

    • Debabrata Mukherjee
    • David J. Moliterno

    OriginalPaper Pages: 293 - 301

16. Time to Treatment and Cost of Thrombolysis: A Multicenter Comparison of tPA and rPA

    • Ali Seyedroudbari
    • E. Richard Kesslcer
    • Daniel E. Hilleman

    OriginalPaper Pages: 303 - 308